Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
AssigneesTitan Pharmaceuticals, Inc., Arizona Board of Regents on Behalf of the University of Arizona
InventorsEugene Morkin, Louis R. Bucalo, Steven Goldman
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for stimulating weight loss or lowering triglyceride levels in an individual in need thereof. In methods of the invention, a pharmaceutical composition comprising a therapeutically effective amount of DITPA, and optionally one or a plurality of lipid lowering agents, is administered to an individual to stimulate weight loss, lower triglyceride and/or lipoprotein levels, and/or to treat one or more symptoms of metabolic syndrome.
Claims29
A method for stimulating weight loss in an overweight mammal, comprising administering to said mammal a therapeutically effective amount of 3,5-diiodothyropropionic acid (“DITPA”), wherein said mammal does not have congestive heart failure.
(canceled)
A method for lowering triglyceride levels in an overweight mammal, comprising administering to said mammal a therapeutically effective amount of 3,5-diiodothyropropionic acid (“DITPA”), wherein said mammal does not have congestive heart failure.
(canceled)
-38. (canceled)
Dependencies are inferred from the claim text.